Lv65
1730 积分 2025-10-10 加入
Inflammaging: a new immune–metabolic viewpoint for age-related diseases
7天前
已完结
Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
1个月前
已完结
Navigating the complexities of drug development for inflammatory bowel disease
1个月前
已完结
The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
1个月前
已完结
The history of Toll-like receptors — redefining innate immunity
1个月前
已完结
Design, synthesis, and biological evaluation of 2,4-diamino pyrimidine derivatives as potent FAK inhibitors with anti-cancer and anti-angiogenesis activities
4个月前
已完结
IL-1β+ macrophages fuel pathogenic inflammation in pancreatic cancer
4个月前
已完结
The present and future of bispecific antibodies for cancer therapy
4个月前
已完结
Reshaping Pfizer’s drug discovery priorities
4个月前
已完结
Cancer interception with KRAS inhibitors in preclinical models of pancreatic ductal adenocarcinoma
5个月前
已完结
皖公网安备34019202002308
